Cargando…
Thrombosis, cancer, and COVID-19
Cancer and coronavirus disease 2019 (COVID-19) have unusual similarities: they both result in a markedly elevated risk of thrombosis, exceptionally high D-dimer levels, and the failure of anticoagulation therapy in some cases. Cancer patients are more vulnerable to COVID-19 infection and have a high...
Autores principales: | Brito-Dellan, Norman, Tsoukalas, Nikolaos, Font, Carme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106567/ https://www.ncbi.nlm.nih.gov/pubmed/35567609 http://dx.doi.org/10.1007/s00520-022-07098-z |
Ejemplares similares
-
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
por: Tsoukalas, Nikolaos, et al.
Publicado: (2022) -
Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
por: Font, Carme, et al.
Publicado: (2022) -
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
por: Cooksley, Tim, et al.
Publicado: (2020) -
Splenic Infarction with Aortic Thrombosis in COVID-19
por: Sztajnbok, Jaques, et al.
Publicado: (2021) -
The Treatment of Venous Thrombosis
Publicado: (1909)